Key Takeaways
- Robigo, an AgBiotech startup, has won the THRIVE Global X Scale-Up Program, receiving investment from SVG Ventures to accelerate its microbial solutions.
- The program is known for nurturing AgriFoodTech innovation, with alumni generating over $1.6 billion in value.
- Robigo’s platform uses precision microbial solutions to combat crop losses caused by pests and diseases, addressing 20–40% of global agricultural production losses.
- The company aims to expand its capabilities through field trials and product development to bring its solutions to market.
What is the significance of Robigo’s win?
Robigo (Profile) has been named the winner of the THRIVE Global X Scale-Up Program. This recognition includes an investment from SVG Ventures and supports Robigo’s ongoing financing efforts to advance its innovative technology.
The THRIVE Accelerator, which has supported over 100 AgriFoodTech companies, has built a reputation for fostering innovation in the sector. Alumni such as Tortuga, Trace Genomics, and Arable have collectively created more than $1.6 billion in value. Robigo now joins this distinguished network, further cementing its position as a leader in sustainable agriculture.
How does Robigo address crop losses?
Robigo’s platform uses bioengineering and data science to tackle crop losses caused by pests and diseases—an issue responsible for 20–40% of global agricultural production losses. With growing public demand for reduced pesticide use, Robigo’s precision microbial solutions offer a sustainable alternative. These solutions harness naturally occurring microbes to protect crops, increase yields, and help agriculture adapt to climate change.
“While the industry is moving toward more biological solutions, growers repeatedly cite consistency of performance as their top concern,” said Dr. Andee Wallace, CEO and Founder of Robigo. “At Robigo, we’re building on nature’s foundation to engineer microbial solutions that provide more reliable and effective crop protection. We are honored to be recognized by SVG Ventures’ THRIVE Global X Scale-Up Program and look forward to demonstrating how our technology delivers industry-leading results, season after season.”
What progress has the company made in advancing its technology?
Over the past year, Robigo has expanded its platform’s capabilities to include new crops, disease targets, and a novel mode of action through lab demonstrations. The company is now focusing on field trials and accelerating product development to bring its precision microbial solutions to market.
“Our mission at SVG Ventures | THRIVE is to support game-changing technologies that are driving sustainability in food and agriculture,” said Danny O’Brien, Managing Director of EMEA & Global Programs. “Robigo’s precision microbial platform is a standout solution addressing one of agriculture’s greatest challenges—disease control—while ensuring environmental safety. We are proud to announce Robigo as the winner of our Global X Scale-Up Program.”